The release concerned the firm's Nu.Q colorectal cancer screening triage test.
Showing 25 of 5115
Manuele has more than 35 years' of global expertise in nuclear medicine
The company signed an exclusive marketing and distribution agreement with TaiMed in March last year
Medibio’s findings provide a significant step forward in assisting veterans.
Agreement covers the entire suite of Mach7 enterprise imaging solutions.
Spectrum would broaden its reach from just monoclonal antibodies to vaccines, recombinant proteins, diagnostic products and cell therapies, Repligen said.
Subject to stock exchange approval, over 57.8mln warrants were repriced to four cents from five cents.
Summit wants to improve absorption of ezutromid in patients with duchenne muscular dystrophy (DMD) through a modified diet and new formulation.
Over 1,000 plaintiffs have sued J&J in the state of Missouri but most are from outside of the state.
According to official research, eczema impacts millions of Americans ..
John Paulson heads up New York-based investment firm Paulson & Co which owns a 5.7% stake in Valeant
The global regenerative medicine market was worth US$18.9 billion in 2016.
"We expect to launch the product in time for the coming flu season,” said Arthur Bedrosian, Lannett chief executive.
Funding from New York-based asset manager, The Lind Partners.
It means the waste fluid disposal system can now be marketed in 32 European countries.
CEO Glyn Edwards is to participate in a DMD pipeline panel discussion at the JMP Securities Life Sciences Conference
Shares rose almost 10% in pre-market in New York after the news
Acceleron dumped its dalantercept drug on Monday following unimpressive data, but investors don’t seem too concerned today
For women who choose reconstructive surgery following a mastectomy.
"It is a pleasure to welcome Gary to the M Pharma team, where he will undoubtedly make an immediate impact,," said Thompson
Aebersold received the Karger Medal from the Barnett Institute of Chemical & Biological Analysis in Boston, Masachusetts.
The consolidation will take effect from Monday and will bump up each share's value while reducing the number of shares in issue
Dr Lucjan Wyrwicz from the Maria Sklodowska-Curie Memorial Cancer Centre, Institute of Oncology, Warsaw will present the data at the 2017 American Society of Clinical Oncology (ASCO) meeting in Chicago, Illinois tomorrow
Dr Scott Powell will provide an update on Volition's business, clinical, regulatory and operational milestones at three investor conferences
Reseach house SeeThruEquity issued an upbeat note on Pressure Biosciences following its first quarter results.